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Background: We isolated a novel monomeric peptide from antler plate polypeptide (APP) of sika deer and found
that it inhibited rat breast cancer cell proliferation and telomerase activity.
Methods: The molecular mass and purity of this polypeptide was determined by ultra performance liquid
chromatography (UPLC) and Bruker micOTOF OllQ TOF mass spectrometry, respectively. The full amino-acid
sequence of the monomeric peptide was analyzed by sequential Edman degradation using a protein/peptide
sequencer. The APP-1 markedly inhibited rat breast cancer cell proliferation as determined with an 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2-H- tetrazolium bromide (MTT) assay. Then, we used flow cytometry to detect the effects of the
monomeric peptide on cell cycle. Relative quantitative fluorescence PCR was used to analyze the expression level
telomerase reverse transcriptase (TERT).
Results: The molecular mass and purity of this polypeptide was 10646 Da and 91.2 %. Amino acid sequence analyses
indicated that the N-terminal amino-acid sequence of this monomeric peptide was: MTKLE DYLEG IVNIF HQYSV. The
results showed that monomeric peptide halted most cancer cells stagnating in the G0/G1 phase. The percentage of
cells in the G0/G1 is higher than control group after the monomeric peptide treatment. Relative quantitative
fluorescence PCR results showed that TERT gene expression level obviously decreased after treatment with the
monomeric peptide compared with control group.
Conclusions: Collectively, the results suggest that this novel and monomeric APP has antitumor activities and imply
that it is likely an important component of antitumor activities in antler plate polypeptide.
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Although velvet antler has been used clinically for thou-
sands of years in China, the antler plate (AP) from Cervus
Nippon Temminck was not previously used in traditional
Chinese medicine. An antler plate (AP) is the ossified disc
between the front of the skull and the velvet antler of sika
deer [1]. AP especially from sika deer produced in Jilin
Province is a precious Chinese medicine material. A char-
acteristic use of AP is to treat mastitis [2–4]. However, it
is so rigid that it is difficult to shatter. For this reason,
researchers have not yet identified the active components.
Here, we report a standardized procedure to overcome this
problem and demonstrate that it can help in utilizing AP.* Correspondence: weisdhu@163.com
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(http://creativecommons.org/publicdomain/zeVelvet antlers, which contain cartilage, bone, epider-
mis, blood vessels, nerves, and other tissues, can grow
rapidly [5, 6]. Scientists in New Zealand have demon-
strated that there are a number of growth factors and
their receptors in velvet antler tip and hypothesize that
these underlie the observed rapid growth [7, 8]. AP is
the ossified disc of velvet antler, and it has exerts some
of the same activities as velvet antler, including promot-
ing wound healing and anti-inflammatory and anti-
bacterial effects [1].
The content of protein in antler plate can reaches up
to 40 %, being one of the main functional components
in antler plate. However, the larger the molecular mass
of protein, the worse the absorption extent. The mono-
meric protein polypeptide is much easier to be absorbed
by the organism compared with the protein of larger
molecular mass. Then, on the basis of former researchesistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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ponent that of true use, choose breast cancer cell line
MA782 in mice as research object in vitro, and discuss
the effect of antler plate on breast cancer cell line
MA782 in mice, which can provide scientific basis to the
further development of antler plate as anticancer re-
sources and also provide possibility to the effective con-
trol of the breast cancer.
In recent years, more and more scientists are focusing
on small molecular protein monomers during the re-
search of antler plate. These studies showed that AP
contains a variety of different active ingredients that
could cure breast hyperplasia and inhibit of breast can-
cer [9–11]. Huang et al previously reported the isolation
of an active polypeptide from AP of sika deer with a mo-
lecular mass of 7127.6u [12], and further demonstrated
that this polypeptide exerted a glucose-cutting activity.
We were interested in determining if other polypeptides
with useful biological activities could be derived from
AP. In this paper, we purified a novel antler plate poly-
peptide (APP, 10646 Da) from the AP of sika deer using
column chromatography and determined that it could
inhibit the proliferation and telomerase activity of rat
breast cancer cell line MA782.
Methods
Cell line
MA782 cells are rat breast cancer cells, growing sticked
a wall. Its cell form is epithelioid. MA782 cells were pur-
chased from (China Center for Type Culture Collection,
Wuhan, China) and maintained in RPMI 1640 with 10 %
fetal bovine serum (Gibco/Invitrogen, Carlsbad, CA,
USA) and 1 % antibiotics (penicillin and streptomycin)
(Gibco/Invitrogen).
Isolation and extraction of total polypeptide
This study was approved by the ethics committee of the
Institute of Life Sciences, Jilin Agriculture University,
Changchun, China. Samples of hard antler plate were
obtained from a 3 year-old male Cervus nippon provided
by Jilin Agricultural University Deer Farm (Changchun,
China). The raw material (500 g) was extracted with pre-
cooled acetic acid solution and further concentrated,
and the residue was lyophilized. The resulting freeze-
dried material (500 mg) was demineralized with a
SephadexG-25 column (10 × 1000 mm) (Pharmacia,
China) that had been pre-equili brated with deionized
water. Proteins peaks were collected and lyophilized.
Monomer peptide separation and purification
As described above, the total peptide (300 mg dry mass)
was applied to a Sephadex G-50 column (10 × 1000 mm)
that had been pre-equilibrated with distilled water. The
total peptide (S2) markedly inhibited MA782 cellproliferation after 72 h (in doses from 10–30 mg/L, as de-
termined with MTT assay). Lyophilized polypeptide S2 was
then purified using reverse-phase high-performance liquid
chromatography (HPLC, Zorbax 300SB C18 9.4 × 250 mm)
(China) [13]. Elution was performed with a linear gradient
system from solvent A (0.1 % trifluoroacetic acid in 15 %
acetonitrile) to solvent B (0.085 % trifluoroacetic acid in
70 % acetonitrile) at a flow rate of 1 mL/min over 30 min,
and absorbance was detected at 280 nm. The final yield of
Peptide samples (APPs) was 5.0 mg (0.010 %, w/w, AP).
Analysis and identification of the monomer peptide
Peptide samples were hydrolyzed at 110 °C for 24 h with
6 M HCl containing 0.1 % phenol, and the hydrolyzate
was analyzed with a Beckman model 6300 automatic
amino acid analyzer (Beckman Coulter, Brea, CA, USA).
Purity and molecular mass was determined by the
UPLC-MS/MS system. The UPLC-MS/MS system con-
sisted of an Agilent 1290 system (Aglient Technologies,
USA) and a Bruker micrOTOF QII (Bruker Daltonics,
USA) mass spectrometer equipped with an electrospray
ionization (ESI) source. Chromatographic separation was
achieved on a Zorbax Stable Bond C18 300A analytical
column (4.6 × 250 mm, 5 μm; Aglient Technologies,
USA) operated at 30 °C. The mobile phase consisted of
0.1 % TFA water (A) and acetonitrile (B), formed by a
gradient elution of 5–5 % (v/v) B at 0–5 min, 5–80 % B
at 5–55 min, and 80–98 % B at 55–60 min. The flow
rate was 1.0 mL/min. The mass spectrometer was oper-
ated in the positive ionization mode. Optimized MS
parameters of capillary and endplate voltage were 4.5 kV
and 500 V, respectively. Nitrogen was used as the dry
gas and nebulizer gas at a rate of 6.0 L/min and pressure
0.8 bar. The dry gas temperature was set at 200 °C.
Argon was used as the collision gas and collision energy
was set to 8 ev for all of the transitions. Data were ac-
quired and analyzed with Bruker Data Analysis (version
4.0 SP 1) [14]. Amino-acid sequence was determined by
sequential Edman degradation using a protein/peptide
sequencer at the Beijing Analyse Centre of Biomedicine
(China). All the processes were performed automatically.
MTT assay
Prepare the protein solution of which the concentration
is 20 μg/mL from the purified monomeric peptide freeze
dried using RPMI-1640 culture solution that do not con-
tain serum, and then filtration sterilization. Then take
cells in logarithmic phase, digest them by trypsin, pre-
pare single cell suspension using RPMI-1640 complete
culture solution, inoculate them into the culture plate of
96 holes in accordance with the density of 3 × 103/hole
after cell counting, the volume of each hole is 200 μL.
Move the culture plate into CO2 incubator, culture it for
24 h under the condition of 37 °C, 5 %CO2, discard the
Table 2 Amino acid composition in APP
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cells that have not accepted the monomeric protein pro-
cessing as control group, and cells that have accepted
the monomeric protein processing as experimental
group. The concentration of the protein is 20 μg/mL re-
spectively, and incubation time is 24 h, 48 h, 72 h re-
spectively. Add 20 μL MTT solution to each hole at 4 h
before the end of the incubation. Abandon the super-
natant at the end of the incubation, add 200 μL DMSO
to each hole, place the plate in incubator for 30 min to
let the crystal substance in cells dissolve sufficiently.
Choose the wavelength of 490 nm, and measure the light
absorption value of each hole using ELIASA [15].
Cell cycle analysis
Cells were seeded in 6-well plates at 50 % confluency. The
next day, we added the monomeric peptide (20 μg/mL
final concentration). After 24, 48, and 72 h, cells were
trypsinized, washed with phosphate-buffered saline (PBS),
and fixed in cold ethanol (75 %) for 24 h at 4 °C. Cells
were then washed with PBS and resuspended in propi-
dium iodium (20 mg/ml) solution containing RNAse
(200 mg/ml) for 30 min in a dark room. Cellular DNA
content was determined with a flow cytometer (Becton
Dickinson, Franklin Lakes, NJ, USA) [15].
TERT mRNA level detection
A TaqMan RNA Assay (Invitrogen) was used for TERT
quantification. The monomeric peptide (20 μg/mL final
concentration) was transfected into rat breast cancer cells
that reached a growth density of 80 %, and total RNA was
extracted from cell culture pellets using TRIzol reagent
(Invitrogen) after 24, 48, and 72 h. For reverse transcription,
1 mg of RNA was used and retranscripted with a Super-
Script II reverse transcriptase kit (Invitrogen). The resulting
cDNA was amplified with TaqMan in the presence of 1.5 μl
gene-specific primers, 1 μl probes, and TaqMan Master
Mix. The primers and probes were supplied by Applied
Biosystems (Foster City, CA, USA) and the sequences are
listed in Table 1. Quantitative real-time PCR was carried
out using Applied Biosystems Step One Plus Real-Time
PCP (Shanghai CpG Biotech Co., Ltd., CA). TERT mRNA
abundance was calculated as the ratio of the copy num-
ber of target mRNA normalized to the copy number of
β-actin mRNA. Reactions were run in duplicates andTable 1 Quantitative real-time PCR primers and probes
TERT Tert -Forward:5- CAACAGAAAGTCATCAACAAAACG–3
Tert -Reverse:5- GCTCCAGCCTATCCACCCT–3
Tert -Taqman-MGB-Probe:5- AAGCAACCCATCCCG–3
β-actin (mBA) mBA-MGB-Forward: GACAGGATGCAGAAGGAGATTACTG
mBA-MGB-Reverse: GCTGATCCACATCTGCTGGAA
mBA-MGB-FAM: FAGATCAAGATCATTGCTCCPrepeated at least three times in optical 96-well plates.
Finally, we calculated the corresponding level using the
2-△△Ct = 2-△Ct treatment -△Ct reference method. Each real-
time PCR assay was performed at least three times [16].
Data analysis
All data are presented as means ± standard deviation (SD).
SPSS version 12.0 software (SPSS Inc., Chicago, IL, USA)
was used for all statistical analyses, and p-values <0.05
were considered to be statistically significant.
Results
Separation and purification of a new monomeric peptide
from APP
Crude total polypeptide extract was treated with acetic
acid buffer and ethanol, analyzed by SDS-PAGE, and the
Coomassie brilliant blue-stained gel (a single band of
approx.3 kDa) suggested that it contained five polypep-
tides. Final purification of crude total peptide extract
was accomplished by column chromato- graphy on a
Sephadex G-50 and reverse-phase HPLC.
APP was isolated as an amorphous white solid. Acid
hydrolysis demonstrated that APP is composed of amino
acids; alanine, glycine, glutamic acid, and proline were
the main amino acid residues, and cysteine was not
present (Table 2). The molecular mass determined by
Bruker micOTOF OllQ TOF was about 10,646 Da. The
purity of the purified peptide was demonstrated to be
91.2 % via HPLC (Fig. 1). An attempt to sequence the
monomeric peptide directly via Edman degradation led
to the conclusion that its N-terminus was open. Thus,







Fig. 1 Purity identification and molecular mass detection of the monomeric peptide. a Mass of the monomeric peptide was determined by Bruker
micOTOF OllQ TOF with an experimental accuracy of ± 0.1 %, the peak is due to solvent interference. The molecular mass of this novel polypeptide
was 10646 Da. b Purity identification of the monomeric peptide by utilizing the HPLC, The purity of this novel polypeptide was 91.2 %
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amino acid sequence of this monomeric peptide was
MTKLEDYLEG IVNIFHQYSV. It was named APP-1.
Restoration of APP-1 inhibits rat breast cancer cell growth
Rat breast cancer cell line MA782 was treated with the
monomeric peptide (20 μg/mL) for 24, 48, and 72 h, and
the effects of this monomeric peptide on cell prolifera-
tion were investigated using MTT assays. Compared
with the control group, the proliferation of MA782 cells
exhibited significantly decreased at 48 h after the mono-
meric peptide treatment (P < 0.01, Fig. 2).
Effect of APP-1 on cell cycle
Rat breast cancer cell line MA782 was treated with the
monomeric peptide (20 μg/mL) for 24, 48, and 72 h, andwe used flow cytometry to assess cell cycle. The results
showed that the monomeric peptide altered the percent-
age of cells in every phase. There was a clear decrease
and increase in the number of cells in the S and G0/G1
phases, respectively. Over time, these differences became
more apparent. Based on these results, we could infer
that the monomeric peptide arrested the cell cycle, and
most cells were in the G0/G1 phase (Fig. 3).
Effect of APP-1 on TERT gene expression
After treatment for 24, 48, and 72 h, we used TRIzol so-
lution to extract total RNA from rat breast cancer cells.
And 1 % agarose gel electrophoresis results showed that
we isolated good-quality RNA. The three electrophoresis
lanes for rRNA (28S, 18S, and 5S) were clear and
complete without degradation or genomic DNA. Thus,
Fig. 2 Effects of the novel monomeric peptide on MA782 cell
proliferation using the MTT method. MA782 cells were treated with
the monomeric peptide as indicated. The rate of cell inhibition was
measured at the indicated times post-transfection using an MTT
assay. Compared with the control, cell inhibition decreased when
cells were treated with the monomeric peptide after 24 h, 48 h, and
72 h. Data are presented as the mean ± SD (n = 3). Similar results were
obtained in three independent experiments. *P < 0.05; **P < 0.01,
compared with the control
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ase and subsequent TERT and β-actin gene amplifica-
tion. Relative fluorescence quantitative PCR showed that
cells treated with the monomeric peptide (20 μg/mL) for
24, 48, and 72 h had decreased TERT gene levels com-
pared with the control group (Fig. 4).Discussion
Gel chromatography and HPLC are widely used in peptide
purification because they offer good separation, speed,
high sample capacity, and high efficiency [17, 18]. The
total peptide of AP contains five kinds of peptides accord-
ing to SDS-PAGE analysis. We first used gel chromatog-
raphy to separate them. Peptides with significantly
different molecular weights are found in total peptide, but
the Sephadex G-50 classification range is 1500–30,000
and could meet the requirements, the selection of Sepha-
dex G-50 as the fill medium was appropriate. Our results
show that this equipment could separate the peptide ef-
fectively, which offered a good foundation for the next
step. We selected a more suitable method to determine
the chromatography parameters and separated out a
monomer peptide with 91.2 % purity. Huang et al [12] re-
ported that the sika antler peptide isolated by ion ex-
change, gel filtration, and reverse phase chromatography,
and MALDI-TOF-MS revealed that the molecular mass
was 7127.6. This result was in accordance with ours, even
though we used a much simpler purification process that
saved time and significantly reduced sample loss. Peptide
purification was good, and the different polarity of HPLCallowed us to separate the constituents and obtain high-
purity APPs.
Native polypeptide drugs have low molecular weights,
are easy to absorb, and have few side effects. They can dir-
ectly correct cytokine imbalances on molecular and cellu-
lar levels. Yunlu et al [19] reported that they successfully
isolated and purified a cytotoxin from Naja naja atra
venom using gel filtration, ion-exchange column chroma-
tography, and hydrophobic interaction chromatography.
They performed in vitro experiments and demonstrated
that this cytotoxin could inhibit proliferation in human
hepatocellular carcinoma BEL-7404, human lung adeno-
carcinoma A549, and mouse melanoma B16 cells. Huang
et al [12] separated a monomeric peptide with a molecular
weight of 7127.6 and treated insulin-resistant HepG2 cells
to determine if there were any effects on glucose con-
sumption. The results showed that the monomeric poly-
peptide had obvious hypoglycemic activity.
We used the rat breast cancer cell line MA782 to assess
the effects of APPs. Many studies have reported the sika
AP can cure mastitis by inhibiting mammary gland hyper-
plasia. However, these treatments were comprised of many
AP peptide components and other Chinese crude
drugs in compound preparations. However, no breast
cancer research utilizing monomeric sika AP polypeptide
has been reported. Here, we obtained a monomeric pep-
tide with a molecular weight of 10,646, which is different
than that obtained by Huang. MTT experiment re-
sults indicated the novel polypeptide could inhibit the
proliferation of MA782 cell. This may be because the
molecular of monomer peptide was small, structure
was simple, and it was easy to digestion and absorption.
So the physiological function and nutrition value could be
more obviously. Therefore, in the follow-up tests, we
would select the novel monomer peptide to continue
experiment later, so we can continue to evaluate mono-
mer peptide inhibition effect from other aspect.
The basic characteristic of a tumor is uncontrolled cell
growth, including reduced apoptosis or increased prolif-
eration. Cancer is largely a cell cycle disease, and cell
cycle suppression is an important topic in cell biology
and oncology research. Daowei and colleagues demon-
strated that earthworm extract can successfully inhibit
ECA-109 and HeLa cancer cell lines [20]; the authors
hypothesized that the tumor cells were arrested in the
G0/G1 period, which eventually led to cell death due to
lack of proliferation. Shuqin et al [21] verified that ac-
tive, low molecular weight anticancer peptides extracted
from goat spleen could inhibit nml-231 breast cancer
cell proliferation by halting the cell cycle. ACBP stopped
cells in the G1 period and inhibited DNA synthesis.
Compared with the control group, the number of G0/G1
phase cells was significantly higher, and the number of S
phase was significantly lower in cells treated with the
Fig. 3 Cell cycle results before and after the monomeric peptide treatment for 24, 48, and 72 h, respectively (b, c, d). The figure a is the contral
group. The y-axis indicates cell number, and the x-axis shows DNA content. The monomeric peptide prevented the entry of MA782 cells into S
phase, and the percentages of cells in G1/G2 in the treated groups are higher than control group; this was especially pronounced in the 72 h
treatment group
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monomeric peptide can effectively halt the cell cycle in a
breast cancer cell line.
Telomerase activity and the occurrence and develop-
ment of most malignant tumors are closely correlated.
Telomerase activity is detectable in 90 % of malignant
tumor tissues, including lung, breast, prostate, and other
major cancers, as well as most leukemias and lymph-
omas. The regulation of telomerase activity is complex.
Telomerase is highly regulated during cell development
and differentiation. Telomerase is a potential diagnostic
and prognostic marker in human tumors consisting of a
specialized ribonucle oprotein polymerase composed of
the RNA subunit, human telomerase RNA (hTR), and a
catalytic protein component, human telomerase reversetranscriptase (hTERT), which can elongate telomeric
DNA using its own RNA subunit as a template. hTR is
ubiquitously and equivalently expressed in both normal
and tumor tissues, but the hTERT subunit is selectively
expressed in a small subset of normal cells, tumor tis-
sues, and tumor-derived cell lines, indicating that hTERT
is the rate-limiting component of telomerase activity.
TERT catalyzes telomere lengthening. In immortalized
cells, TERT gene expression levels increase, whereas it is
not expressed in normal cells [22, 23]. TERT expression
is directly proportional to telomerase activity, and it
plays an important role in telomerase activity regulation
[24, 25]. Shan et al [26] reported that a venom polypep-
tide increased apoptosis in the human hepatic carcinoma
cell line BEL-7402 and decreased telomerase activity.
Fig. 4 Detection of TERT gene expression level by real-time PCR. Rat
MA782 cells were treated with the monomeric peptide, and TERT
mRNA expression was assessed using quantitative PCR after 24, 48,
and 72 h. Each experiment was performed in triplicate. TERT mRNA
expression levels were significantly decreased at all-time points in
comparison with control cells. Data are presented as the mean ± SD
(n = 3). Similar results were obtained in three independent experiments.
*P< 0.05; **P< 0.01, compared with the control
Hu et al. BMC Complementary and Alternative Medicine  (2015) 15:328 Page 7 of 8Similarly, Guisheng et al [27] found that treating human
hepatic carcinoma Bel7404 cells with scorpion venom
polypeptide effectively reduced telomerase activity. Col-
lectively, these lines of evidence suggest that telomerase
activity inhibition is a possible mechanism for halting
cancer cell proliferation.
We found that the monomeric peptide effectively de-
creased TERT mRNA levels compared with the control
group, which corresponded to the observed MTT results
and cell cycle changes. Our findings suggest that APPs
might inhibit breast cancer cell proliferation by regulating
telomerase activity. Others researchs have implicated that
the TERT gene in regulation of breast cancer telomerase
activity. Thus, it is possible that APPs also regulates tel-
omerase activity by degrading TERT gene mRNA level.
Perhaps inhibition of telomerase activity is one of mecha-
nisms by which APPs prevents breast cancer cells from
proliferating. However, whether APPs was the only com-
ponent that lowered TERT expression requires further
study. Even so, the results of this experiment expand the
theoretical basis for further study into the anti-tumor
mechanisms of sika AP.
Conclusion
In conclusion, whether there are other active compo-
nents in sika antler plate depends on how the native
material is purified. We used a two-step process and
obtained a new monomeric peptide that effectively
inhibited MA782 cell proliferation. The mechanisms
may involve a reduction in TERT gene expression,
and cell cycle arrest. However, whether this single
peptide has other functions should be researched
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